Biopharma companies are embracing pre-use post-sterilization integrity testing in line with stricter GMP requirements.
Pharmaceutical manufacturers in the EU may have to approach the manufacturing of sterile drugs a little differently under the EU’s Annex 1 covering good manufacturing practices (GMPs), which goes into ...
Correction: This article was edited on 15 September 2022 to correct Jorg Zimmermann's title. Sterile drug manufacturers should start preparing a gap analysis to identify what needs to be done to ...
RADNOR, PA — Avantor, Inc. (NYSE: AVTR) has introduced a new line of pre-engineered PUPSIT (pre-use, post-sterilization integrity testing) assemblies and a comprehensive sterile sampling suite, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results